YRNA expression in prostate cancer patients: diagnostic and prognostic implications.
Yuri TolkachEva-Maria NiehoffAnna Franziska StahlChenming ZhaoGlen KristiansenStefan C MüllerJoerg EllingerPublished in: World journal of urology (2018)
The expression of YRNAs is altered in PCA and associated with poor prognosis (RNY5). Possible diagnostic role of YRNAs in prostate cancer should be investigated in further studies.